| Characterization of GATA-1+ hemangioblastic cells in the mouse embryo. | | Yokomizo T, Takahashi S, Mochizuki N, Kuroha T, Ema M, Wakamatsu A, Shimizu R, Ohneda O, Osato M, Okada H, Komori T, Ogawa M, Nishikawa S, Ito Y, and Yamamoto M. | EMBO J    26, 184-96  (2007) | | |
| | | |
| Inchinkoto, an herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers. | | Okada K, Shoda J, Kano M, Suzuki S, Ohtake N, Yamamoto M, Takahashi H, Utsunomiya H, Oda K, Sato K, Watanabe A, Ishii T, Itoh K, Yamamoto M, Yokoi T, Yoshizato K, Sugiyama Y and Suzuki H. | Am J Physiol Gastrointestinal Liver Physiol   Epub ahead of print,   (2007) | | |
| | | |
| Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. | | Yates MS, Tauchi M, Katsuoka F, Flanders KC, Liby KT, Honda T, Gribble GW, Johnson DA, Johnson JA, Burton NC, Guilarte TR, Yamamoto M, Sporn MB, and Kensler TW. | Mol Cancer Therapeutics   1, 54-62  (2007) | | |
| | | |
| Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3-methylimidazo [4,5-f] quinoline. | | Kitamura Y, Umemura T, Kanki K, Kodama Y, Kitamoto S, Saito K, Itoh K, Yamamoto M, Masegi T, Nishikawa A, and Hirose M. | Cancer Sci   98, 19-24  (2007) | | |
| | | |
| Functional polymorphisms in the transcription factor NRF2 increase the risk of acute lung injury. | | Marzec JM, Christie JD, Reddy SP, Jedlicka AE, Vuong H, Lanken PN, Aplenc R, Yamamoto T, Yamamoto M, Cho, H-Y, and Kleeberger SR. | FASEB J   ,  in press  (2007) | | |
| | | |
| Dynamic regulation of Gata factor levels is more important than their identity. | | Ferreira R, Wai A, Shimizu R, Gillemans N, Rottier R, von Lindern M, Ohneda K, Grosveld F, Yamamoto M, and Philipsen S. | Blood   109, 5481-5490  (2007) | | |
| | | |
| Nrf2 Neh5 domain is differentially utilized in the transactivation of cytoprotective genes. | | Zhang J, Hosoya T, Maruyama A, Nishikawa K, Maher JM, Ohta T, Motohashi H, Fukamizu A, Shibahara S, Itoh K, and Yamamoto M. | Biochem J   404, 459-466  (2007) | | |
| | | |
| A Gata2 intronic enhancer confers its pan-endothelia-specific regulation. | | Khandekar M, Brandt W, Zhou Y, Dagenais S, Glover TW, Suzuki N, Shimizu R, Yamamoto M, Lim K-C, and Engel JD. | Development   139, 1703-1712  (2007) | | |
| | | |
| Embryonic and fetal beta-globin gene repression by the orphan nuclear receptors, TR2 and TR4. | | Tanabe O, McPhee D, Kobayashi S, Shen Y, Brandt W, Jiang X, Campbell AD, Chen YT, Chang C, Yamamoto M, Tanimoto K, Engel JD. | EMBO J   26(9), 2295-2306  (2007) | | |
| | | |
| Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis. | | Iida K, Itoh K, Maher JM, Kumagai Y, Oyasu R, Mori Y, Fukushima S, Shimazui T, Akaza H, and Yamamoto M. | Carcinogenesis   in press,   (2007) | | |
| | | |
|